# 6th Annual Midwest Tumor Microenvironment Meeting

> **NIH NIH R13** · UNIVERSITY OF KANSAS MEDICAL CENTER · 2020 · $5,000

## Abstract

Project Summary
We request partial funding for the Midwest Tumor Microenvironment Meeting to be held at the University of
Kansas Medical Center in Kansas City, KS on May 18-20, 2020. The meeting was inaugurated in 2015 and is
the only meeting on tumor microenvironment in the Midwest region. This meeting has established itself as a
highly valued contribution to the interdisciplinary scientific field of the tumor microenvironment, with focus on the
role of immune system and the stroma in cancer growth and progression. The 2020 conference co-organizers
are Shrikant Anant, Ph.D. and Sufi M. Thomas, Ph.D. The meeting will convene 18 speakers and up to 200
participants. A special effort will be made to recruit minority participants. The meeting will also provide a forum
for trainees and scientists who are in early stages of their career to present their data and network with others in
the field. Dr. David Tuveson from the Cold Spring Harbor Laboratory, an expert in exploring the fundamental
biology of malignancy and thereby identify new diagnostic and treatment strategies will present his recent work
on patient-derived organoid models. In addition, Dr. Theresa Whiteside from the University of Pittsburgh Medical
Center, who investigates the role of the immune function in tumorigenesis will present her recent work on stroma-
derived exosomes and their role in tumorigenesis in her keynote address. Topics for presentation will be multi-
disciplinary including novel technologies to study issues related to tumor-stroma interactions, as well as the
various cellular and extracellular matrix factors affecting tumorigenesis. In addition to invited speakers, trainees
and young investigators will have the opportunity to present in oral presentation sessions. In addition, there will
be two poster sessions, which will allow all participants to contribute to the meeting. Opportunities will especially
be given to your investigators, women, and minorities to interact with the presenting faculty and representatives
from the National Cancer Institute Tumor Microenvironment Program. Funding through this R13 mechanism is
requested to defray the cost of participating in the meeting for young investigators and trainees. We expect that
researchers dealing with various aspects of the tumor microenvironment will cultivate new collaborations and
the trainees will identify new mentors as a result of the networking opportunity from this meeting.

## Key facts

- **NIH application ID:** 10002411
- **Project number:** 1R13CA247227-01A1
- **Recipient organization:** UNIVERSITY OF KANSAS MEDICAL CENTER
- **Principal Investigator:** Shrikant Anant
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $5,000
- **Award type:** 1
- **Project period:** 2020-05-01 → 2023-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10002411

## Citation

> US National Institutes of Health, RePORTER application 10002411, 6th Annual Midwest Tumor Microenvironment Meeting (1R13CA247227-01A1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10002411. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*